Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Norway Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20093
20112
20121
20131
20151
20161
20172
20183
20191
20211
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting4
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Tesaro, Inc.3
AGO Study Group2
AstraZeneca2
Genmab2
Merck Sharp & Dohme LLC2
Nordic Society of Gynaecological Oncology - Clinical Trials Unit2
AGO Research GmbH1
Boehringer Ingelheim1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms24
Fallopian Tube Neoplasms10
Carcinoma, Ovarian Epithelial6
Peritoneal Neoplasms4
Brenner Tumor1
Genital Diseases, Female1
Neoplasm Metastasis1
Ovarian Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.